Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Open-market buy Senior VP, COO & CFO bought 5,400 shares at $4.45 ($24,041)
  2. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.40 ($43,962)
  3. 3 Insider Initial Statement of Ownership
  4. 5 Insider Annual Insider Trading Report
  5. 5 Insider Annual Insider Trading Report
  6. 4 Exercise or conversion Chief Executive Officer acquired 49,600 shares (option exercise)
  7. 4 Open-market sale Vice President & Secretary sold 27,128 shares at an average $7.52 ($204,063)
  8. 4 Exercise or conversion Vice President & Secretary acquired 125,000 shares (option exercise)
  9. 4 Option exercise Director acquired 1,037,058 shares (option exercise)
  10. 4 Option exercise 10% owner acquired 115,520 shares (option exercise)
  11. 4/A Option exercise 10% owner acquired 220,086 shares (option exercise)
  12. 4 Option exercise Vice President & Secretary acquired 21,586 shares (option exercise)
  13. 4 Option exercise 10% owner acquired 220,086 shares (option exercise)
  14. 4 Insider Changes in Ownership
  15. 4 Derivatives Options or other derivatives
  16. 4 Option exercise Director acquired 447,004 shares (option exercise)
  17. 4 Open-market sale Chief Financial Officer sold 60,000 shares at an average $4.45 ($267,178)
  18. 4 Exercise or conversion Chief Financial Officer acquired 80,000 shares (option exercise)
  19. 4 Option exercise Vice President & Secretary acquired 23,750 shares (option exercise)
  20. 4 Option exercise 10% owner acquired 680 shares (option exercise)

Page 20 of 37 · 722 filings